Perspectum

Company profile

About Perspectum

Perspectum is a global medical technology company advancing quantitative imaging for metabolic, liver, and multi-organ health assessment. The company's proprietary technology extracts actionable biomarkers from medical imaging in an intuitive and streamlined way, moving beyond conventional one-dimensional diagnostics to provide comprehensive, multi-dimensional insights. Perspectum's solutions are designed to be safe, fast, and accessible, helping healthcare providers deliver precision medicine tailored to individual patient needs. The company offers solutions across two primary segments: pharma solutions supporting drug development and clinical trials in areas including body composition, cardiometabolic disease, autoimmune disease, MASLD/MASH & cirrhosis, gastrointestinal disease, and oncology; and clinical solutions including LiverMultiScan, CoverScan, MRCP+, Hepatica, and the Perspectum Portal. These technologies enable non-invasive assessment and monitoring of complex conditions. Founded by renowned physicians and scientists including co-founder Sir Michael Brady, Perspectum collaborates with world-leading experts to accelerate research on metabolic diseases, cancer, diabetes, and other chronic conditions. The company operates the Oxford Community Diagnostic Centre and has established partnerships to expand access to advanced MRI diagnostics. Perspectum's patient-first approach emphasizes that every case is unique, with a goal of building a kinder healthcare system through customized solutions and better outcomes.

Company description · Perspectum official website